Last updated on November 2016

A Phase 3 Clinical Trial for Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS-C).


Brief description of study

A Phase 3 Clinical Trial for Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS-C).

Detailed Study Description

A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor (study medication) for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C).

Clinical Study Identifier: TX146350

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.